Status:

COMPLETED

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Immune Tolerance Network (ITN)

Conditions:

Lupus Nephritis

Lupus Erythematosus, Systemic

Eligibility:

All Genders

16+ years

Phase:

PHASE2

Brief Summary

This study is for individuals with lupus who have developed complications in their kidneys, or lupus nephritis. The study will determine whether adding the experimental medication abatacept to standar...

Detailed Description

Lupus nephritis is an inflammation of the kidney that occurs in patients with systemic lupus erythematosus (SLE). It is caused by the immune system attacking the kidney and is among the most serious c...

Eligibility Criteria

Inclusion

  • Diagnosis of systemic lupus erythematosus (SLE) by American College of Rheumatology (ACR) criteria
  • Active lupus nephritis (defined by: kidney biopsy documentation within the last 12 months using International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification- proliferative nephritis, active urinary sediment, urine protein-to-creatinine ratio \> 1, low complement C3)
  • Positive antinuclear antibody (ANA) test result at time of study entry

Exclusion

  • End stage renal disease
  • Use of cyclophosphamide in the past year
  • Neutropenia, thrombocytopenia, moderately severe anemia
  • Active infection, including HIV, hepatitis B or C
  • History of cancer, except carcinoma in situ and treated basal and squamous cell carcinomas
  • Pregnant or breastfeeding

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

137 Patients enrolled

Trial Details

Trial ID

NCT00774852

Start Date

November 1 2008

End Date

June 1 2014

Last Update

February 8 2016

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

University of Alabama, Birmingham

Birmingham, Alabama, United States, 35294

2

University of California San Diego

La Jolla, California, United States, 92037

3

Cedars Sinai Medical Center

Los Angeles, California, United States, 90048

4

University of California San Francisco

San Francisco, California, United States, 94143